These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26408540)

  • 1. Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
    Yoshioka K; Otani H; Shimazu T; Fujita M; Iwasaka T; Shiojima I
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1782-91. PubMed ID: 26408540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.
    Takimoto E; Champion HC; Li M; Ren S; Rodriguez ER; Tavazzi B; Lazzarino G; Paolocci N; Gabrielson KL; Wang Y; Kass DA
    J Clin Invest; 2005 May; 115(5):1221-31. PubMed ID: 15841206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
    Jo H; Otani H; Jo F; Shimazu T; Okazaki T; Yoshioka K; Fujita M; Kosaki A; Iwasaka T
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):485-93. PubMed ID: 21554376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling.
    Hashimoto T; Sivakumaran V; Carnicer R; Zhu G; Hahn VS; Bedja D; Recalde A; Duglan D; Channon KM; Casadei B; Kass DA
    J Am Heart Assoc; 2016 Mar; 5(3):e003208. PubMed ID: 27001967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase 3 deficiency limits adverse ventricular remodeling after pressure overload in insulin resistance.
    Kurtz B; Thibault HB; Raher MJ; Popovich JR; Cawley S; Atochin DN; Hayton S; Shakartzi HR; Huang PL; Bloch KD; Buys E; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2093-101. PubMed ID: 21856905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.
    Ichinose F; Bloch KD; Wu JC; Hataishi R; Aretz HT; Picard MH; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1070-5. PubMed ID: 14644766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rats are protected from the stress of chronic pressure overload compared with mice.
    Nishimura K; Oydanich M; Zhang J; Babici D; Fraidenraich D; Vatner DE; Vatner SF
    Am J Physiol Regul Integr Comp Physiol; 2020 May; 318(5):R894-R900. PubMed ID: 32209023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
    You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.
    Moens AL; Leyton-Mange JS; Niu X; Yang R; Cingolani O; Arkenbout EK; Champion HC; Bedja D; Gabrielson KL; Chen J; Xia Y; Hale AB; Channon KM; Halushka MK; Barker N; Wuyts FL; Kaminski PM; Wolin MS; Kass DA; Barouch LA
    J Mol Cell Cardiol; 2009 Nov; 47(5):576-85. PubMed ID: 19766235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
    Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial reverse remodeling after pressure unloading is associated with maintained cardiac mechanoenergetics in a rat model of left ventricular hypertrophy.
    Ruppert M; Korkmaz-Icöz S; Li S; Németh BT; Hegedűs P; Brlecic P; Mátyás C; Zorn M; Merkely B; Karck M; Radovits T; Szabó G
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H592-603. PubMed ID: 27342874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
    Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
    J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matúsková J; Lupták I; Pincíková T; Krajcírovicová K; Stvrtina S; Pomsár J; Pelouch V; Paulis L; Pechánová O
    Physiol Res; 2007; 56 Suppl 2():S25-S32. PubMed ID: 17824810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload.
    Buys ES; Raher MJ; Blake SL; Neilan TG; Graveline AR; Passeri JJ; Llano M; Perez-Sanz TM; Ichinose F; Janssens S; Zapol WM; Picard MH; Bloch KD; Scherrer-Crosbie M
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H620-7. PubMed ID: 17416602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
    Deng J; Wang YW; Chen WM; Wu Q; Huang XN
    Biol Pharm Bull; 2010; 33(4):631-5. PubMed ID: 20410597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.